Ocuphire Pharma Comprehensive Income 2010-2024 | IRD
Ocuphire Pharma comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Ocuphire Pharma Annual Comprehensive Income (Millions of US $) |
2023 |
$ |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$-0 |
2017 |
$-0 |
2016 |
$-0 |
2015 |
$-0 |
2014 |
$-0 |
2013 |
$ |
2012 |
$ |
2011 |
$ |
2010 |
$-0 |
2009 |
$ |
Ocuphire Pharma Quarterly Comprehensive Income (Millions of US $) |
2024-06-30 |
|
2024-03-31 |
|
2023-12-31 |
|
2023-09-30 |
|
2023-06-30 |
|
2023-03-31 |
|
2022-12-31 |
|
2022-09-30 |
|
2022-06-30 |
|
2022-03-31 |
|
2021-12-31 |
|
2021-09-30 |
|
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
$0 |
2019-06-30 |
$0 |
2019-03-31 |
$-0 |
2018-12-31 |
$-0 |
2018-09-30 |
$-0 |
2018-06-30 |
$-0 |
2018-03-31 |
$-0 |
2017-12-31 |
$-0 |
2017-09-30 |
$-0 |
2017-06-30 |
$-0 |
2017-03-31 |
$-0 |
2016-12-31 |
$-0 |
2016-09-30 |
$-0 |
2016-06-30 |
$0 |
2016-03-31 |
$-0 |
2015-12-31 |
$-0 |
2015-09-30 |
$0 |
2015-06-30 |
$0 |
2015-03-31 |
$0 |
2014-12-31 |
$-0 |
2014-09-30 |
$-0 |
2014-06-30 |
|
2014-03-31 |
|
2013-12-31 |
|
2013-09-30 |
|
2013-06-30 |
|
2013-03-31 |
|
2012-12-31 |
|
2012-09-30 |
|
2012-06-30 |
$-60 |
2012-03-31 |
|
2011-12-31 |
|
2011-09-30 |
$0 |
2011-06-30 |
|
2011-03-31 |
$-0 |
2010-12-31 |
$-0 |
2010-09-30 |
$0 |
2010-06-30 |
|
2010-03-31 |
|
2009-12-31 |
|
2009-09-30 |
|
2009-06-30 |
|
2009-03-31 |
$-0 |
Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|